Related Experiment Video
Updated: Nov 11, 2025

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
Published on: October 27, 2023
Genetically predicted serum urate levels have no causal role on depression or other psychiatric disorders
Sizheng Steven Zhao1, Yu Qian2, Sarah L Mackie3,4
1Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Abstract:
Clinicians are advised caution in reducing serum urate for gout management due to observational associations with risk of neuropsychiatric diseases. We examined the causal effect of genetically predicted serum urate levels on the risk of major depressive disorder (MDD), anxiety, and related psychiatric disorders using two-sample Mendelian randomization (MR). We identified single-nucleotide polymorphisms (SNPs) associated with serum urate from a genome-wide association study (GWAS) of 110,347 European-descent individuals. The causal effect of serum urate on MDD was tested using summary data from a GWAS of 135,458 cases and 344,901 controls of European descent. MR was performed using random-effects inverse variance-weighted method and a series of sensitivity analyses. This approach was repeated using summary GWAS data for anxiety, bipolar disorder, post-traumatic stress disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, schizophrenia, and anorexia nervosa. We identified 30 SNPs associated with serum urate. Genetically predicted urate levels were not causally associated with risk of MDD (OR 0.98; 95% CI 0.94, 1.03), anxiety (OR 0.90; 95% CI 0.80, 1.02), or the other psychiatric conditions (OR range 0.95 to 1.06). Results were similar in sensitivity analyses. We found no evidence that genetically predicted serum urate has a causal effect on risk of MDD, anxiety, or other psychiatric disorders. Key Points • Clinicians are advised to be cautious about reducing the serum urate level too far in gout management, citing observational associations between low serum urate levels and various neuropsychiatric diseases. • In this two-sample Mendelian randomization study, we found no evidence for a causal link between genetically predicted serum urate level and the development of major depressive, anxiety, or other related psychiatric disorders. • Future revisions of clinical guidelines may need to reconsider recommendations regarding lower limits for serum urate levels.
Insights
This study found no causal link between genetically predicted serum urate levels and major depressive disorder or anxiety. These findings suggest current gout management guidelines may need reevaluation regarding serum urate targets.
Area of Science:
- Genetics and Psychiatry
- Metabolic Disorders
- Epidemiology
Background:
- Observational studies suggest a link between low serum urate and neuropsychiatric diseases, prompting caution in gout management.
- The potential causal relationship between serum urate levels and psychiatric disorders remains unclear.
Purpose of the Study:
- To investigate the causal effect of genetically predicted serum urate levels on the risk of major depressive disorder (MDD) and anxiety.
- To explore the association between serum urate and other psychiatric conditions including bipolar disorder, PTSD, OCD, ADHD, schizophrenia, and anorexia nervosa.
Main Methods:
- Utilized two-sample Mendelian randomization (MR) with genome-wide association study (GWAS) data.
- Identified 30 single-nucleotide polymorphisms (SNPs) associated with serum urate in 110,347 individuals.
- Applied random-effects inverse variance-weighted method and sensitivity analyses for robustness.
Main Results:
- Genetically predicted serum urate levels showed no causal association with the risk of major depressive disorder (MDD) (OR 0.98; 95% CI 0.94, 1.03).
- No causal link was observed for anxiety (OR 0.90; 95% CI 0.80, 1.02) or other psychiatric disorders (OR range 0.95 to 1.06).
- Sensitivity analyses confirmed the absence of a causal relationship.
Conclusions:
- This study provides no evidence for a causal effect of genetically predicted serum urate on the risk of MDD, anxiety, or other psychiatric disorders.
- Findings challenge the caution advised for reducing serum urate levels in gout management based on observational data.
- Clinical guidelines on serum urate targets for gout may require reconsideration in light of these genetic findings.
More Related Videos
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Serum Studies: Renal Function Tests
Depression: Overview
G-protein Coupled Receptors
Antidepressant Drugs: MAOIs and Other Agents

